Market Size of United States Bariatric Surgery Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
Market Size (2024) | USD 0.85 Billion |
Market Size (2029) | USD 1.09 Billion |
CAGR (2024 - 2029) | 5.19 % |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
United States Bariatric Surgery Market Analysis
The United States Bariatric Surgery Market size is estimated at USD 0.85 billion in 2024, and is expected to reach USD 1.09 billion by 2029, growing at a CAGR of 5.19% during the forecast period (2024-2029).
There are certain factors propelling the growth of the market, including increasing obesity patients, growing government initiatives to curb obesity, and a rising prevalence rate of type 2 diabetes and heart diseases in the country.
As per United States National Health Statistics Reports published in June 2021, among adults aged 20 and over, the prevalence of obesity was 41.9%, severe obesity was 9.2%, and diabetes was 14.8%. The increase in the prevalence of obesity among the population is expected to drive the bariatric surgery market in the United States. Furthermore, the presence of established healthcare infrastructure along with the presence of a large number of market players in the country is expected to boost market growth over the forecast period. For instance, in September 2020, Ethicon, part of Johnson & Johnson Medical Devices Companies, launched ECHELON ENDOPATH Staple Line Reinforcement (SLR), a buttressing device designed to reduce potential complications during bariatric procedures.